Lilly Reports Q2 2024 Financial Results, Raises ... - Eli …

ELI LILLY AND COMPANYQuarterly Results | Eli Lilly and CompanyLilly provides update on 2024 revenue guidance, announces 2025 revenue ...

$11
OFF

Eli Lilly Q2 2024 Earnings: LLY Stock Surges On Strong Results

2 weeks from now

Aug 8, 2024 · Eli Lilly reports stellar Q2 2024 results, beating estimates with $11.3B revenue. ... Eli Lilly's innovative treatments and robust clinical development drive record-breaking Q2 2024 …

girolino.com

$45
OFF

LLY Earnings: Eli Lilly Reports Impressive Q2 Results; Huge

2 weeks from now

Aug 8, 2024 · This premium adds a strong point in favor of LLY stock.Eli Lily’s Forward GuidanceLooking ahead, Lilly has raised its 2024 revenue guidance to a range of $45.4 billion …

nasdaq.com

36%
OFF

Eli Lilly Stock Surges After Diabetes, Weight-Loss Sales Wallop ...

2 weeks from now

Aug 8, 2024 · Eli Lilly Stock Boosted By Sales, Profit Beat The success of Mounjaro and Zepbound led to a strong second-quarter beat. Total sales advanced 36% to $11.3 billion, …

investors.com

$15.10
OFF

Eli Lilly Q2 Results Top Estimates; Boosts FY24 Outlook

2 weeks from now

Aug 8, 2024 · Looking ahead to fiscal 2024, Eli Lilly now projects earnings in a range of $15.10 to $15.60 per share and adjusted earnings in a range of $16.10 to $16.60 per share on revenues …

businessinsider.com

$3.92
OFF

Eli Lilly (LLY) Q2 Earnings Top, Mounjaro, Zepbound Drive View

2 weeks from now

Aug 8, 2024 · Eli Lilly and Company LLY reported second-quarter 2024 adjusted earnings per share (“EPS”) of $3.92, which comprehensively beat the Zacks Consensus Estimate of $2.64 …

yahoo.com

455%
OFF

What’s Next For Eli Lilly Stock After A Solid Q2? - Trefis.com

2 weeks from now

Aug 12, 2024 · LLY stock has seen extremely strong gains of 455% from levels of $160 in early January 2021 to around $890 now, vs. an increase of about 40% for the S&P 500 over this …

trefis.com

61%
OFF

Eli Lilly (LLY) Q2 2024 Earnings Call Transcript

2 weeks from now

Aug 8, 2024 · Eli Lilly (LLY 1.61%) Q2 2024 Earnings Call Aug 08, 2024, 10:00 a.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: …

fool.com

455%
OFF

What’s Next For Eli Lilly Stock After A Solid Q2? - Forbes

2 weeks from now

Aug 13, 2024 · Firstly, let us look at its stock performance. LLY stock has seen extremely strong gains of 455% from levels of $160 in early January 2021 to around $890 now, vs. an increase …

forbes.com

$3.92
OFF

Eli Lilly (LLY) Surpasses Q2 Earnings And Revenue Estimates

2 weeks from now

Aug 8, 2024 · Eli Lilly (LLY) came out with quarterly earnings of $3.92 per share, beating the Zacks Consensus Estimate of $2.64 per share. This compares to earnings of $2.11 per share …

nasdaq.com

$1.18
OFF

Eli Lilly And Company (LLY) Earnings Date And Reports 2025

2 weeks from now

2 days ago · Eli Lilly and Company posted Q3 2024 earnings on October 30, 2024, reporting an EPS of $1.18, which missed analysts' consensus estimates of $1.52 by $0.34.Quarterly …

marketbeat.com

$10
OFF

Will The Supply Shortage Weigh On Eli Lilly's Q2? - Nasdaq

2 weeks from now

Aug 7, 2024 · Eli Lilly stock (NYSE: LLY) will report its Q2 results on Thursday, August 8. The pharmaceutical giant is expected to garner $10 billion in sales and $2.70 in adjusted earnings …

nasdaq.com

36%
OFF

Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue ...

2 weeks from now

Aug 8, 2024 · Second-Quarter Reported Results In Q2 2024, worldwide revenue was $11.30 billion, an increase of 36% compared with Q2 2023, driven by a 27% increase in volume and a …

prnewswire.com

$45
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

1 day ago · 2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance. Q4 2024 revenue is expected …

lilly.com

32%
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

1 day ago · Eli Lilly and Company (NYSE: LLY) today announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, which represents growth of 32% …

yahoo.com

9%
OFF

Eli Lilly's Q4 2024 Earnings: What To Expect - Nasdaq

2 weeks from now

1 day ago · Eli Lilly is scheduled to release ... Analysts expect Eli Lilly’s EPS to climb 107.9% to $13.14 in fiscal 2024, ... analysts’ consensus opinion on LLY stock is bullish, with a “Strong …

nasdaq.com

FAQs about Lilly Reports Q2 2024 Financial Results, Raises ... - Eli … Coupon?

How much will Eli Lilly make in 2024?

Looking ahead to fiscal 2024, Eli Lilly now projects earnings in a range of $15.10 to $15.60 per share and adjusted earnings in a range of $16.10 to $16.60 per share on revenues between $45.4 billion and $46.6 billion. ...

How did Eli Lilly perform in Q2 2024?

Eli Lilly and Company LLY reported second-quarter 2024 adjusted earnings per share (“EPS”) of $3.92, which comprehensively beat the Zacks Consensus Estimate of $2.64 per share. Earnings rose 86% year over year. Revenues of $11.3 billion rose 36% year over year. Total revenues beat the Zacks Consensus Estimate of $9.83 billion. ...

How good are Eli Lilly's second-quarter 2024 financial results?

Written by Annika Masrani for TipRanks -> Eli Lilly’s (LLY) second-quarter 2024 financial results are in, and they are nothing short of impressive. The pharmaceutical giant saw a staggering 36% increase in revenue compared to the same quarter last year, thanks largely to its key drugs: Mounjaro, Zepbound, and Verzenio. ...

When did Eli Lilly and company announce their last quarterly earnings?

Eli Lilly and Company (NYSE:LLY) last announced its quarterly earning data on Wednesday, October 30, 2024. Learn more on LLY's earnings history. ...

When will Eli Lilly's Q2 results be released?

Written by Trefis Team for Trefis -> Eli Lilly stock (NYSE: LLY) will report its Q2 results on Thursday, August 8. The pharmaceutical giant is expected to garner $10 billion in sales and $2.70 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly’s diabetes drug – Mounjaro – and its weight-loss drug – Zepbound. ...

Should you buy Lilly stock in 2024?

This premium adds a strong point in favor of LLY stock. Looking ahead, Lilly has raised its 2024 revenue guidance to a range of $45.4 billion to $46.6 billion. This optimistic forecast reflects strong performance from Mounjaro and Zepbound, along with improved clarity on production expansions and international launches. ...